Free tool
FAERS Monitor: Latuda
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 200603 or its brand name (Latuda, Lurasidone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
20,965
Serious
9,380
45% of reports
Hospitalization
3,095
Death reported
581
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use2,089
- drug ineffective1,897
- anxiety1,241
- feeling abnormal1,170
- depression1,146
- weight increased1,104
- somnolence1,081
- nausea1,061
- insomnia1,016
- suicidal ideation1,011
- fatigue954
- dyskinesia832
- suicide attempt800
- tremor719
- vomiting682
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 102 |
| 2012 | 234 |
| 2013 | 229 |
| 2014 | 413 |
| 2015 | 745 |
| 2016 | 1,036 |
| 2017 | 2,654 |
| 2018 | 2,711 |
| 2019 | 3,110 |
| 2020 | 2,319 |
| 2021 | 2,827 |
| 2022 | 1,830 |
| 2023 | 1,066 |
| 2024 | 740 |
| 2025 | 545 |
| 2026 | 402 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,194 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dyskinesiaSignal | 832 | 20.9 | 19.6 | 15,490 |
| suicide attemptSignal | 800 | 13.4 | 12.5 | 9,073 |
| suicidal ideationSignal | 1,011 | 11.2 | 10.5 | 9,311 |
| somnolenceSignal | 1,081 | 5.4 | 5.1 | 3,898 |
| depressionSignal | 1,146 | 5.1 | 4.8 | 3,766 |
| weight increasedSignal | 1,104 | 5.0 | 4.7 | 3,512 |
| feeling abnormalSignal | 1,170 | 4.9 | 4.7 | 3,671 |
| anxietySignal | 1,241 | 4.4 | 4.2 | 3,275 |
| tremorSignal | 719 | 4.4 | 4.1 | 1,866 |
| insomniaSignal | 1,016 | 3.8 | 3.6 | 2,148 |
| off label useSignal | 2,089 | 2.4 | 2.3 | 1,769 |
| vomiting | 682 | 1.5 | 1.4 | 99 |
| drug ineffective | 1,897 | 1.4 | 1.4 | 276 |
| nausea | 1,061 | 1.3 | 1.3 | 97 |
| fatigue | 954 | 1.2 | 1.2 | 42 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.